PACS CEO Jason Hulse Murray Sells $1.8M of Stock

Jason Hulse Murray, Co-Founder, CEO and Chairman of PACS Group, Inc. PACS, sold 37,477 shares of stock on October 20, 2026. According to a Form 4 filing with the SEC, the shares were sold at an average price of $47.65 for a total value of about $1.8 million.

PACS PACS Group, Inc.

$47.43 ▲ +20.05% year to date

1M 3M YTD

Daily close · Oct 21, 2026

Inside Jason Hulse Murray's PACS Trade

The planned transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Following the sale, the chief executive still holds 54,277,423 shares in the medical care facilities operator. This transaction follows several other sales by the executive earlier in October 2026.

Other Institutional Activity in PACS Group

Other large institutional investors adjusted their positions in the healthcare provider during the mid-year reporting period. Cohen & Steers Inc. reduced its holdings by 780,054 shares, ending with 8,343,381 shares valued at about $390.1 million. Crewe Advisors LLC grew its holdings by 553,034 shares, ending with 3,307,188 shares worth about $154.6 million. American Century Companies Inc added 1,298,580 shares to hold 3,108,196 shares valued at roughly $145.3 million. Ameriprise Financial, Inc. lifted its stake by 873,697 shares to reach 1,995,116 shares worth about $93.3 million. Alyeska Investment Group, L.P. pared back its position by 1,463,403 shares, finishing with 1,539,065 shares valued at about $72.0 million.

PACS Group, Inc. Stock Holds Steady

PACS Group shares closed at $47.72 on October 20, 2026. The stock recently traded around $47.72 as of October 21, 2026, which is about equal to its event-day close and slightly below its 52-week high of $49.49.

Recent Earnings

The company reported trailing twelve month revenue of $5.55 billion and basic earnings of $1.71 per share. The next earnings report is scheduled for November 9, 2026.

Insider Buying and Selling at PACS Group, Inc.

Insider transactions at PACS Group have included multiple sales by top leaders over recent months. Co-Founder and Executive Vice Chair Mark Hancock sold 138,069 shares on June 25, 2026, for about $5.6 million. President and COO Joshua Jergensen sold 40,000 shares on October 14, 2026, for about $1.8 million. CEO Jason Hulse Murray previously sold 110,035 shares on October 15, 2026, for about $5.2 million, and another 8,462 shares on October 16, 2026, for about $402,875.

Analysts Set New Price Targets

Wall Street firms have maintained positive outlooks on the stock through late summer and early autumn. On August 6, 2026, UBS maintained its Buy rating while raising its price target from $57.00 to $60.00. RBC Capital maintained an Outperform rating on August 6, 2026, lifting its target from $52.00 to $57.00. Truist Securities maintained a Buy rating on August 6, 2026, taking its target from $52.00 up to $62.00. Oppenheimer maintained an Outperform rating on August 10, 2026, pushing its target from $48.00 to $57.00. Later, on September 4, 2026, JP Morgan maintained an Overweight rating and raised its target from $47.00 to $58.00. Overall, the stock carries a strong buy recommendation key from six analysts covering the company.

About PACS Group

PACS Group operates skilled nursing and assisted living facilities across the United States. The company manages senior care properties and senior living assets to serve growing healthcare needs.

Bottom Line

Investors will look toward the upcoming earnings release on November 9, 2026, for updated financial results. Future Form 4 filings will show whether executive selling continues at this pace.